72.19.Z - Other research and experimental development on natural sciences and engineering
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | -9,3 | -1,1 | 0 | 100 |
Gross profit (loss) | -9,3 | -1,1 | 0 | 100 |
EBITDA | -9,3 | -1,1 | 0 | 100 |
Short time liabilities | 0,5 | 0,5 | 0,5 | 0 |
Other operating costs | 0 | 0 | 0 | 0 |
Equity capital | 3 | 1,8 | 1,8 | 0 |
Operating profit (EBIT) | -9,3 | -1,1 | 0 | 100 |
Assets | 3,5 | 2,3 | 2,3 | 0 |
Net profit (loss) | -9,3 | -1,1 | 0 | 100 |
Cash | 0,7 | 0,2 | 0,2 | 0 |
Net income from sale | 5,1 | 0 | 0 | -100 |
Liabilities and provisions for liabilities | 0,5 | 0,5 | 0,5 | 0 |
Working assets | 3,5 | 2,3 | 2,3 | 0 |
Other income costs | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -315,2 | -61,2 | 0 | 61,2 |
Equity capital to total assets | 85,5 | 78,5 | 78,5 | 0 |
Gross profit margin | -181,9 | -112 035 | -111 853,1 | |
EBITDA Margin | -181,9 | -112 035 | -111 853,1 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 36 | 182 500 | 2 147 483 648 | 2 147 301 148 |
Current financial liquidity indicator | 6.897361755371094 | 4.660200119018555 | 4.660200119018555 | 0 |
Net dept to EBITDA | 0.019590087234973907 | -0.2757174074649811 | -0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane